X4 Pharmaceuticals XFOR
NASDAQ XFOR
$2.83 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

X4 Pharmaceuticals (XFOR) Cash & Current Investments (2017 - 2026)

Updated

X4 Pharmaceuticals (XFOR) reported Cash & Current Investments of $195.1 million for Q2 2026, up 397.4% from $39.22 million a year earlier but down 10.1% from the prior quarter.

Analysis

X4 Pharmaceuticals (XFOR) Cash & Current Investments (2017 - 2026) Analysis & Trends

At the end of FY2025, X4 Pharmaceuticals posted Cash & Current Investments of $217.05 million, up 289.7% from FY2024.

  • Cash & Current Investments has a five-year compound annual growth rate of 22.5% (FY2020 to FY2025).
  • By year, Cash & Current Investments came in at $55.7 million in FY2024 (-43.9%), $99.22 million in FY2023 (-18.5%), $121.72 million in FY2022 (+48.8%) and $81.79 million in FY2021 (+3.9%).
  • Five-year quarterly Cash & Current Investments spans a low of $39.22 million in Q2 2025 and a high of $217.05 million in Q4 2025.
  • Year over year, Cash & Current Investments has now increased in each of the last three quarters, with growth averaging 115.1% over the last eight quarters.
  • The high point for year-over-year Cash & Current Investments in five years was Q1 2026 (growth of 438.8%); the low point was Q2 2025 (a decline of 73.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $216.91 million (Q1 2026), $217.05 million (Q4 2025) and $69.63 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 X4 Pharmaceuticals 357.55 Mn -341.13 Mn 7.19 Mn 195.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 195.10 Mn
Mar 31, 2026 216.91 Mn
Dec 31, 2025 217.05 Mn
Sep 30, 2025 69.63 Mn
Jun 30, 2025 39.22 Mn
Mar 31, 2025 40.26 Mn
Dec 31, 2024 55.70 Mn
Sep 30, 2024 97.41 Mn
Jun 30, 2024 147.22 Mn
Mar 31, 2024 60.49 Mn
Dec 31, 2023 99.22 Mn
Sep 30, 2023 131.58 Mn
Jun 30, 2023 136.43 Mn
Mar 31, 2023 93.41 Mn
Dec 31, 2022 121.72 Mn
Sep 30, 2022 79.90 Mn
Jun 30, 2022 47.40 Mn
Mar 31, 2022 66.43 Mn
Dec 31, 2021 81.79 Mn
Sep 30, 2021 76.40 Mn
API Access

X4 Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=XFOR&period=max&api_key=YOUR_API_KEY